<?xml version="1.0" encoding="UTF-8"?>
<p>Eltrombopag is a thrombopoietin receptor (also known as c-Mpl or MPL) agonist that is used for the treatment of thrombocytopenia, including hepatitis C virus-associated thrombocytopenia [
 <xref rid="B1-cells-09-00031" ref-type="bibr">1</xref>,
 <xref rid="B2-cells-09-00031" ref-type="bibr">2</xref>,
 <xref rid="B3-cells-09-00031" ref-type="bibr">3</xref>]. Its use has also been suggested for the treatment of cytopenias after hematopoietic stem cell transplantations and case reports support its safety and efficacy [
 <xref rid="B4-cells-09-00031" ref-type="bibr">4</xref>,
 <xref rid="B5-cells-09-00031" ref-type="bibr">5</xref>,
 <xref rid="B6-cells-09-00031" ref-type="bibr">6</xref>,
 <xref rid="B7-cells-09-00031" ref-type="bibr">7</xref>,
 <xref rid="B8-cells-09-00031" ref-type="bibr">8</xref>,
 <xref rid="B9-cells-09-00031" ref-type="bibr">9</xref>].
</p>
